1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Enveric Biosciences Inc (ENVB)
  7. Quote


Enveric Biosciences Stock Price

-0.06 (-3.24%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,824,768
Bid Price 1.77
Ask Price 1.79
News -
Day High 1.83


52 Week Range


Day Low 1.7304
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Enveric Biosciences Inc ENVB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -3.24% 1.79 19:56:10
Open Price Low Price High Price Close Price Prev Close
1.83 1.7304 1.83 1.77 1.85
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,384 1,824,768 $ 1.77 $ 3,231,022 - 1.54 - 7.00
Last Trade Time Type Quantity Stock Price Currency
19:58:38 formt 200 $ 1.79 USD


Draw Mode:

Enveric Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 38.36M 21.43M 19.13M $ - $ - -0.10 0.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.62M 33.70%

more financials information »

Enveric Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENVB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.951.961.73041.891,092,026-0.16-8.21%
1 Month2.15752.381.72731.991,695,179-0.3675-17.03%
3 Months1.973.741.542.633,932,816-0.18-9.14%
6 Months2.383.741.542.582,613,146-0.59-24.79%
1 Year6.007.001.543.563,828,171-4.21-70.17%
3 Years6.007.001.543.563,828,171-4.21-70.17%
5 Years6.007.001.543.563,828,171-4.21-70.17%

Enveric Biosciences Description

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Your Recent History
Enveric Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.